(5-Cyano-2-Methoxyphenyl)Boronic Acid → 6-(4-Chloro-phenyl)-2-(2,4-dimethoxy-pyrimidin-5-yl)-5-(1,3-dimethyl-2-oxo-hexahydro-pyrimidin-5-yl)-1-isopropyl-5,6-dihydro-1H-pyrrolo[3,4-b]pyrrol-4-one

HRID 2204383Notes

Reaction equation

HRID 2204383 reaction equation
Br[C:2]1[N:6]([CH:7]([CH3:9])[CH3:8])[C:5]2[CH:10]([C:23]3[CH:28]=[CH:27][C:26]([Cl:29])=[CH:25][CH:24]=3)[N:11]([CH:14]3[CH2:19][N:18]([CH3:20])[C:17](=[O:21])[N:16]([CH3:22])[CH2:15]3)[C:12](=[O:13])[C:4]=2[CH:3]=1.[CH3:30][O:31][C:32]1C=[C:36]([O:38][CH3:39])[C:35](B(O)O)=[CH:34][N:33]=1.BrC1[N:48](C(C)C)C2C(C3C=CC(Cl)=CC=3)N(C3C=C(Cl)C=CC=3C)C(=O)C=2C=1.C(C1C=CC(OC)=C(B(O)O)C=1)#N>>[Cl:29][C:26]1[CH:27]=[CH:28][C:23]([CH:10]2[C:5]3[N:6]([CH:7]([CH3:9])[CH3:8])[C:2]([C:35]4[C:36]([O:38][CH3:39])=[N:48][C:32]([O:31][CH3:30])=[N:33][CH:34]=4)=[CH:3][C:4]=3[C:12](=[O:13])[N:11]2[CH:14]2[CH2:15][N:16]([CH3:22])[C:17](=[O:21])[N:18]([CH3:20])[CH2:19]2)=[CH:24][CH:25]=1

Participants

5

Reactant 4

HCID 23005336(5-Cyano-2-Methoxyphenyl)Boronic AcidHCID 536303594,6-Dimethoxypyridine-3-boronic acidHCID 867031692-bromo-5-(5-chloro-2-methyl-phenyl)-6-(4-chloro-phenyl)-1-isopropyl-5,6-dihydro-1H-pyrrolo[3,4-b]pyrrol-4-oneHCID 867031912-bromo-6-(4-chloro-phenyl)-5-(1,3-dimethyl-2-oxo-hexahydro-pyrimidin-5-yl)-1-isopropyl-5,6-dihydro-1H-pyrrolo[3,4-b]pyrrol-4-one2×

Product 1

HCID 867031906-(4-Chloro-phenyl)-2-(2,4-dimethoxy-pyrimidin-5-yl)-5-(1,3-dimethyl-2-oxo-hexahydro-pyrimidin-5-yl)-1-isopropyl-5,6-dihydro-1H-pyrrolo[3,4-b]pyrrol-4-one

Procedure

The title compound was prepared in analogy to the procedure described for Example 17 but 2-bromo-6-(4-chloro-phenyl)-5-(1,3-dimethyl-2-oxo-hexahydro-pyrimidin-5-yl)-1-isopropyl-5,6-dihydro-1H-pyrrolo[3,4-b]pyrrol-4-one (Intermediate P) and 2,4-dimethoxypyridine-5-boronic acid were used instead of 2-bromo-5-(5-chloro-2-methyl-phenyl)-6-(4-chloro-phenyl)-1-isopropyl-5,6-dihydro-1H-pyrrolo[3,4-b]pyrrol-4-one and 5-cyano-2-methoxyphenylboronic acid respectively. The title compound was obtained as a white solid. tR: 2.95 min (HPLC 5); ESI-MS: tR=0.99 min, [M+H]+539/541 (LC-MS 1); 1H-NMR (d6-DMSO, 400 MHz): 8.26 (s, 1H), 7.51 (m, 2H), 7.24-7.48 (m, 2H), 6.25 (s, 1H), 5.85 (s, 1H), 4.08 (m, 1H), 3.95 (s, 3H), 3.90 (m, 1H), 3.89 (s, 3H), 3.81 (m, 1H), 3.23 (m, 1H), 3.11 (m, 1H), 2.93 (m, 1H), 2.70 (s, 3H), 2.61 (s, 3H), 1.28 (m, 3H), 0.40 (m, 3H).

Workup

  1. customThe title compound was prepared in analogy to the procedure

Sources & evidence

ORD record
ord-d2382dd7b8a24f3c8032db80beadfdb9
Source dataset
uspto-grants-2016_06
Patent number
US09365576B2

Reaction notes

Loading…